Viewing Study NCT02055066


Ignite Creation Date: 2025-12-24 @ 4:09 PM
Ignite Modification Date: 2026-02-21 @ 9:24 PM
Study NCT ID: NCT02055066
Status: COMPLETED
Last Update Posted: 2017-04-21
First Post: 2014-01-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1b Study of ARGX-111 in Patients With Advanced Cancer.
Sponsor: argenx
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cancer View
None c-MET View